Despite variable clinical presentation, PSP, AD and FTD are characterized by abnormal deposition of tau protein in neurons and/or glia in the frontal, temporal, and insular cortical gray matter and hindbrain1,2. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.